EcoDrugPlus

Ribosomal Protein L13a

Ensembl ID : ENSFCAG00000009194
Gene Symbol: RPL13A
5 Cross references
297 Possible Orthologues:

Ribosomal Protein L17

Ensembl ID : ENSFCAG00000011342
Gene Symbol: RPL17
4 Cross references
136 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSFCAG00000008652
Gene Symbol: RPL18
4 Cross references
265 Possible Orthologues:

Ribosomal Protein L19

Ensembl ID : ENSFCAG00000037023
Gene Symbol: RPL19
5 Cross references
308 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSFCAG00000037105
Gene Symbol: RPL22
5 Cross references
232 Possible Orthologues:

Ribosomal Protein L23

Ensembl ID : ENSFCAG00000014502
Gene Symbol: RPL23
5 Cross references
210 Possible Orthologues:

Ribosomal Protein L24

Ensembl ID : ENSFCAG00000003327
Gene Symbol: RPL24
5 Cross references
236 Possible Orthologues:

Ribosomal Protein L26

Ensembl ID : ENSFCAG00000011259
Gene Symbol: RPL26
5 Cross references
230 Possible Orthologues:

Ribosomal Protein L27

Ensembl ID : ENSFCAG00000013142
Gene Symbol: RPL27
5 Cross references
187 Possible Orthologues:

Ribosomal Protein L28

Ensembl ID : ENSFCAG00000005639
Gene Symbol: RPL28
4 Cross references
204 Possible Orthologues:

Ribosomal Protein L3

Ensembl ID : ENSFCAG00000005820
Gene Symbol: RPL3
5 Cross references
296 Possible Orthologues:

Ribosomal Protein L32

Ensembl ID : ENSFCAG00000030450
Gene Symbol: RPL32
5 Cross references
99 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).